作者
Josep M. Llovet,Sergio Ricci,Vincenzo Mazzaferro,Philip Hilgard,Edward Gane,Jean Frédéric Blanc,Ana Carolina Soares de Oliveira,Armando Santoro,Jean‐Luc Raoul,Alejandro Forner,Myron Schwartz,Camillo Porta,Stefan Zeuzem,Luigi Bolondi,Tim F. Greten,Peter R. Galle,Jean François Seitz,Ivan Borbath,Dieter Häussinger,Tom Giannaris,Minghua Shan,M. Moscovici,D. Voliotis,Jordi Bruix
摘要
No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma.
个性的紫菜
酸化土壤改良
张泽崇
gjww
shinysparrow
寻道图强
star
benben
学习快乐
忐忑的远山
凤凰
坚强的广山
小尹同学
寻寻觅觅呢
SOLOMON
maox1aoxin
宜醉宜游宜睡
iVANPENNY
不安青牛
sars518
皖公网安备34019202002308
